These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 7878956)
1. Vascularized bone marrow transplantation in rats: evidence for amplification of hematolymphoid chimerism and freedom from graft-versus-host reaction. Llull R; Murase N; Ye Q; Manez R; Demetris AJ; Fournier V; Starzl TE Transplant Proc; 1995 Feb; 27(1):164-5. PubMed ID: 7878956 [No Abstract] [Full Text] [Related]
2. Multilineage amplification of graft-vs-host disease-resistant chimerism following rat vascularized bone marrow allotransplantation. Llull R; Murase N; Demetris AJ; Ye Q; Manez R; Starzl TE Transplant Proc; 1995 Aug; 27(4):2363-4. PubMed ID: 7544504 [No Abstract] [Full Text] [Related]
3. Optimizing chimerism level through bone marrow transplantation and irradiation to induce long-term tolerance to composite tissue allotransplantation. Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK J Surg Res; 2012 Nov; 178(1):487-93. PubMed ID: 22484382 [TBL] [Abstract][Full Text] [Related]
4. Vascularized bone marrow transplantation (VBMT): induction of stable mixed T-cell chimerism and transplantation tolerance in unmodified recipients. Yazdi B; Patel MP; Ramsamooj R; Llull R; Achauer BM; Black KS; Hewitt CW Transplant Proc; 1991 Feb; 23(1 Pt 1):739-40. PubMed ID: 1990672 [TBL] [Abstract][Full Text] [Related]
5. Chimerism, graft-vs-host disease, rejection, and their association with reciprocal donor-host immune reactions after cell, organ, and composite tissue transplantation. Llull R; Murase N; Ye Q; Demetris AJ; Starzl TE Transplant Proc; 1997; 29(1-2):1203-4. PubMed ID: 9123273 [No Abstract] [Full Text] [Related]
6. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation. Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257 [TBL] [Abstract][Full Text] [Related]
7. Cellular basis of acquired immunologic tolerance following total bowel transplantation in rats. I. Relation between donor lymphocyte chimerism and host-cell-mediated immunity. Masaki Y; Kimura H; Oohara T Transplant Proc; 1995 Apr; 27(2):1585-8. PubMed ID: 7536971 [No Abstract] [Full Text] [Related]
8. Vascularized bone marrow transplantation and graft versus host disease: morphometric analysis of muscle. Woolley DS; Hou A; Strande L; Tatem L; Mathews M; Hewitt CW Transplant Proc; 1994 Dec; 26(6):3321-2. PubMed ID: 7998154 [No Abstract] [Full Text] [Related]
9. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts. Colson YL; Zadach K; Nalesnik M; Ildstad ST Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703 [TBL] [Abstract][Full Text] [Related]
10. Absence of graft-versus-host disease in the isolated vascularized bone marrow transplant. Tai CY; Strande LF; Eydelman R; Sheng X; VanTran JL; Matthews MS; Hewitt CW Transplantation; 2004 Jan; 77(2):316-9. PubMed ID: 14743002 [TBL] [Abstract][Full Text] [Related]
11. Bone marrow augmentation for heart, liver, and small bowel transplantation: prolongation of graft survival and incidence of graft-versus-host disease. Murase N; Demetris AJ; Fujisaki S; Tanabe M; Qing Y; Todo S; Starzl TE Transplant Proc; 1995 Feb; 27(1):174-5. PubMed ID: 7533386 [No Abstract] [Full Text] [Related]
12. Inhibition of alloreactivity in the popliteal lymph node assay by malononitrilamides. Schorlemmer HU; Bartlett RR; Kurrle R Transplant Proc; 1998 Jun; 30(4):968-70. PubMed ID: 9636391 [No Abstract] [Full Text] [Related]
13. Prevention of graft-versus-host disease after bone marrow and small bowel transplantation by ultraviolet B modulation of bone marrow cells. Chowdhury NC; Jin MX; Hardy MA; Oluwole SF Transplant Proc; 1993 Feb; 25(1 Pt 1):475-6. PubMed ID: 8438384 [No Abstract] [Full Text] [Related]
14. Analysis of V beta T-cell receptor repertoire of effector mechanisms in acute and chronic graft versus host disease. Fischer AC; Ruvolo PP; Horwitz LR; Hess AD Transplant Proc; 1995 Feb; 27(1):1366-9. PubMed ID: 7878914 [No Abstract] [Full Text] [Related]
15. Development of stable mixed T cell chimerism and transplantation tolerance without immune modulation in recipients of vascularized bone marrow allografts. Hewitt CW; Ramsamooj R; Patel MP; Yazdi B; Achauer BM; Black KS Transplantation; 1990 Nov; 50(5):766-72. PubMed ID: 2238052 [TBL] [Abstract][Full Text] [Related]
16. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade. Foster RD; Pham S; Li S; Aitouche A Transplantation; 2003 Sep; 76(6):988-94. PubMed ID: 14508367 [TBL] [Abstract][Full Text] [Related]
17. Characteristics and functions of inflammatory cells isolated from acute graft-versus-host disease target organs after bone marrow transplantation in the rat. Renkonen R; Leszczynski D; Wangel A; Häyry P Transplant Proc; 1987 Feb; 19(1 Pt 3):2689. PubMed ID: 3274579 [No Abstract] [Full Text] [Related]
18. Bone marrow engraftment and GVHD following bone marrow transplantation across a concordant xenogeneic barrier (mouse to rat). Li H; Selvaggi G; Ricordi C; Inverardi L Transplant Proc; 1997 Jun; 29(4):2190-1. PubMed ID: 9193584 [No Abstract] [Full Text] [Related]
19. Mesenteric and intraepithelial lymphocytes are insufficient to cause rejection but able to mediate lethal graft-versus-host disease in small bowel transplants. Xia W; Brandeis JM; Sayegh M; Kirkman RL Transplant Proc; 1994 Jun; 26(3):1508-9. PubMed ID: 8030013 [No Abstract] [Full Text] [Related]
20. Different routes of donor-derived hematopoietic stem cell transplantation for donor-specific chimerism induction across MHC barrier. Siemionow MZ; Klimczak A; Unal S Transplant Proc; 2005; 37(1):62-4. PubMed ID: 15808547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]